INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 112 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2017. The put-call ratio across all filers is 1.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $279,000 | +114.6% | 79,700 | +444.4% | 0.01% | +66.7% |
Q3 2017 | $130,000 | -35.3% | 14,640 | -23.3% | 0.00% | -25.0% |
Q1 2017 | $201,000 | -71.4% | 19,080 | +12.6% | 0.00% | -66.7% |
Q1 2014 | $702,000 | +12.7% | 16,950 | +5.3% | 0.01% | +33.3% |
Q4 2013 | $623,000 | +83.8% | 16,090 | +65.9% | 0.01% | +50.0% |
Q3 2013 | $339,000 | – | 9,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 5,406,844 | $52,014,000 | 0.66% |
ETF MANAGERS GROUP, LLC | 282,268 | $3,255,000 | 0.24% |
Mirae Asset Global Investments Co., Ltd. | 1,470,996 | $14,151,000 | 0.19% |
Financial Gravity Companies, Inc. | 4,467 | $42,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 67,200 | $646,000 | 0.04% |
TCI Wealth Advisors, Inc. | 7,766 | $75,000 | 0.03% |
Freedom Investment Management, Inc. | 64,741 | $623,000 | 0.03% |
GAM Holding AG | 83,940 | $808,000 | 0.02% |
SFMG, LLC | 11,994 | $115,000 | 0.02% |
SHELL ASSET MANAGEMENT CO | 95,127 | $915,000 | 0.02% |